- Novo Nordisk CEO to exit role May 16, 2025
- Takeda investigational drug shows efficacy in narcolepsy May 15, 2025
- GSK to expand hepatology pipeline with potential best-in-class therapy May 14, 2025
- Novel breast cancer treatment approach significantly enhances survival May 13, 2025
- World-first approval supports AstraZeneca’s sustainability goals May 12, 2025
- Innovative CAR T therapy could deliver in broader therapeutic settings, research suggests May 9, 2025
- Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with STELARA (ustekinumab) May 16, 2025
- Join Us! The Future of Biotech Regulation Webinar May 16, 2025
- Third Circuit Affirms Rejection of AstraZeneca’s Challenges to IRA Drug Price Negotiation Program May 15, 2025
- President Trump Issues Two Executive Orders Concerning the Affordability and Accessibility of Drugs May 15, 2025
- EMA Issues Positive CHMP Opinions for Biocon’s Denosumab Biosimilars May 9, 2025
- Resetting the Walk-Away Price: How GoodRx Data Reveals New Realities of Prescription Abandonment May 16, 2025
- How Large PBMs Make Money Today: A 2025 Drug Channels Update May 13, 2025
- From Barriers to Bridges: Rethinking Medication Access for 2025 May 9, 2025
- Follow the 340B Dollar: Senator Cassidy Exposes How CVS Health and Walgreens Profit as 340B Contract Pharmacies May 6, 2025
- Claritas Rx’s Webinar: Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence May 5, 2025
- Unlocking the Gate: The Critical First 24 Hours of Patient Hub Engagement May 2, 2025
- Drug Channels News Roundup, April 2025: Amazon Rx Update, Express Scripts’ Spend Trends, Gold Cards, and CMS Acronym Absurdity April 28, 2025